Key facts
- Method AI’s last known valuation is $31.0M (Aug 2025).
- It has raised $25.0M; the latest was Early Stage VC ($20.2M) in Aug 2025.
- Notable investors include JobsOhio Ventures, Cleveland Clinic.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Method AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Method AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Method AI
Developer of an artificial intelligence surgical navigation platform designed to improve outcomes in robotic oncology procedures. The company's product leverages deep tissue imaging and machine learning algorithms to generate surgical plans and provide physicians with real-time guidance, enabling more precise and effective cancer surgeries.
- Sector
- Healthcare
- HQ
- Needham, MA, United States
- Founded
- 2021
- Employees
- 10
- Website
- mthd.ai/
- Ownership
- Privately Held (backing)
Method AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Method AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Method AI in its N-PORT filings yet. We sweep new filings monthly.